(1) For purposes of this section: (a) "Cancer drug treatment regimen" means a prescription drug used to treat cancer, manage its symptoms, or provide continuity of care for a cancer patient. (b) "Cancer drug treatment regimen" includes: (i) a chemotherapy drug administered intravenously, orally, rectally, or by dermal methods; and (ii) a drug used to support cancer treatment, including a drug used to treat, alleviate, or minimize physical and psychological symptoms or pain, to improve patient tolerance of cancer treatments, or to prepare a patient for a subsequent course of therapy. (c) "Cancer drug treatment regimen" does not mean a drug listed under federal law as a Schedule I, II, or III drug.

(a) "Cancer drug treatment regimen" means a prescription drug used to treat cancer, manage its symptoms, or provide continuity of care for a cancer patient.

(b) "Cancer drug treatment regimen" includes: (i) a chemotherapy drug administered intravenously, orally, rectally, or by dermal methods; and (ii) a drug used to support cancer treatment, including a drug used to treat, alleviate, or minimize physical and psychological symptoms or pain, to improve patient tolerance of cancer treatments, or to prepare a patient for a subsequent course of therapy.

(i) a chemotherapy drug administered intravenously, orally, rectally, or by dermal methods; and

(ii) a drug used to support cancer treatment, including a drug used to treat, alleviate, or minimize physical and psychological symptoms or pain, to improve patient tolerance of cancer treatments, or to prepare a patient for a subsequent course of therapy.

(c) "Cancer drug treatment regimen" does not mean a drug listed under federal law as a Schedule I, II, or III drug.

(2) An individual may be licensed as a dispensing medical practitioner with a scope of practice that permits the dispensing medical practitioner to prescribe and dispense a cancer drug treatment regimen if the individual: (a) is licensed as described in Subsections 58-17b-102(23)(a)(i) and (ii); and (b) is certified or eligible to be certified by: (i) the American Board of Internal Medicine in medical oncology; or (ii) the American Board of Urology.

(a) is licensed as described in Subsections 58-17b-102(23)(a)(i) and (ii); and

(b) is certified or eligible to be certified by: (i) the American Board of Internal Medicine in medical oncology; or (ii) the American Board of Urology.

(i) the American Board of Internal Medicine in medical oncology; or

(ii) the American Board of Urology.

(3) A dispensing medical practitioner authorized to prescribe and dispense a cancer drug treatment regimen under this section may prescribe and dispense a cancer drug treatment regimen: (a) to the practitioner's patient who is currently undergoing chemotherapy in an outpatient clinic setting; and (b) if the practitioner determines that providing the cancer drug treatment regimen to the patient in the outpatient clinic setting is in the best interest of the patient or provides better access to care for the patient.

(a) to the practitioner's patient who is currently undergoing chemotherapy in an outpatient clinic setting; and

(b) if the practitioner determines that providing the cancer drug treatment regimen to the patient in the outpatient clinic setting is in the best interest of the patient or provides better access to care for the patient.